EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Journal of Young Women’s Breast Cancer and Health

ISSN 3050-7162 · Ovid Technologies (Wolters Kluwer Health)

Latest articles

  1. Genomic Risk Evaluation Using Oncotype DX in Young Women (Aged ≤40) With Early-stage, ER-positive, Human Epidermal Growth Factor Receptor 2-negative, and Node-negative Breast Cancer

    Rodoniki Iosifidou, George Kapetsis, Spiridon Giannoulakis, Nikolaos Tsoulos, Grigorios Xepapadakis, Christos Markopoulos, Konstantinos Papazisis, Maria Paraskeva, Maria Kaparelou, Georgios Lainakis, Angeliki Fotarelli, Foteini Pavlidou, Elena Fountzilas, Emmanouil Saloustros, Sofia Karageorgopoulou, Sofia Triantafillidou, Stavros Intzes, Filippos Koinis, Vasileios Venizelos

    Published: 2025DOI: 10.4103/ywbc.ywbc_4_25

Volumes

2026 · 82025 · 122024 · 11

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.